Results 291 to 300 of about 1,040,831 (304)

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Ca-A Cancer Journal for Clinicians, 2018
Farhad Islami, Ann Goding Sauer Msph, Kimberly D Miller   +2 more
exaly  

Expanding the medicinal chemistry synthetic toolbox

Nature Reviews Drug Discovery, 2018
Jonas Boström, Gyorgy M Keseru
exaly  

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Lancet, The, 2012
Burkert Pieske, Amil M Shah, Milton Packer   +2 more
exaly  

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine, 2020
Burkert Pieske, Kevin J Anstrom, Adrian F Hernandez   +2 more
exaly  

Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study

Lancet, The, 2016
Francisco Campelo-Parada, William T Abraham, Josep Rodés-Cabau   +2 more
exaly  

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

Lancet, The, 2020
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock   +2 more
exaly  

Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial

Lancet, The, 2011
Vanessa E Murphy, Kirsten J Mccaffery, Vicki L Clifton   +2 more
exaly  

Chemistry-to-gene screens in Caenorhabditis elegans

Nature Reviews Drug Discovery, 2005
Steven D Buckingham, David B Sattelle
exaly  

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Lancet, The, 2003
Salim Yusuf, Karl Swedberg, Christopher B Granger   +2 more
exaly  

Spironolactone for Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2014
Bertram Pitt, Marc Pfeffer, Inder S Anand   +2 more
exaly